Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avita Medical (RCEL)
NASDAQ:RCEL
Avita Medical (RCEL) Stock Price & Analysis
310 Followers
RCEL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.16 - $21.70
Previous Close$9.46
Volume261.77K
Average Volume (3M)213.43K
Market Cap
$243.19M
Enterprise Value$195.64M
Total Cash (Recent Filing)$89.06M
Total Debt (Recent Filing)$41.51M
Price to Earnings (P/E)-6.8
Beta2.28
Next Earnings
May 13, 2024EPS Estimate
-$0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.40
Shares Outstanding25,706,662
10 Day Avg. Volume432,283
30 Day Avg. Volume213,431
Standard Deviation0.19
R-Squared0.14
Alpha-0.00341
Financial Highlights & Ratios
Price to Book (P/B)5.01
Price to Sales (P/S)4.97
Price to Cash Flow (P/CF)-5.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.90
Enterprise Value/Gross Profit4.62
Enterprise Value/Ebitda-5.98
Forecast
1Y Price Target
$26.80Price Target Upside176.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Avita Medical News
Ownership Overview
2.55% Insiders
9.58% Mutual Funds
10.87% Other Institutional Investors
76.99% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RCEL FAQ
What was Avita Medical’s price range in the past 12 months?
Avita Medical lowest stock price was $9.16 and its highest was $21.70 in the past 12 months.
What is Avita Medical’s market cap?
Currently, no data Available
When is Avita Medical’s upcoming earnings report date?
Avita Medical’s upcoming earnings report date is May 13, 2024 which is in 24 days.
How were Avita Medical’s earnings last quarter?
Avita Medical released its earnings results on Feb 22, 2024. The company reported -$0.28 earnings per share for the quarter, beating the consensus estimate of -$0.379 by $0.099.
Is Avita Medical overvalued?
According to Wall Street analysts Avita Medical’s price is currently Undervalued.
Does Avita Medical pay dividends?
Avita Medical does not currently pay dividends.
What is Avita Medical’s EPS estimate?
Avita Medical’s EPS estimate is -$0.38.
How many shares outstanding does Avita Medical have?
Avita Medical has 25,706,661 shares outstanding.
What happened to Avita Medical’s price movement after its last earnings report?
Avita Medical reported an EPS of -$0.28 in its last earnings report, beating expectations of -$0.379. Following the earnings report the stock price went up 0.529%.
Which hedge fund is a major shareholder of Avita Medical?
Among the largest hedge funds holding Avita Medical’s share is Driehaus Capital Management LLC. It holds Avita Medical’s shares valued at 3M.
---
Avita Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$26.80 (176.29% Upside)
$26.80 (176.29% Upside)
Blogger Sentiment
Bullish
RCEL Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 286.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $21.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.1%
Last 30 Days ▼ 10.8%
Last 30 Days ▼ 10.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.89%
12-Months-Change
Fundamentals
Return on Equity
-52.89%
Trailing 12-Months
Asset Growth
13.61%
Trailing 12-Months
Company Description
Avita Medical
Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company was founded on December 21, 1992 and is headquartered in Royston, the United Kingdom.
---
RCEL Earnings Call
Q4 2024
0:00 / 0:00
---
RCEL Revenue Breakdown
99.27% Commercial sales
0.67% Services for emergency preparedness
0.07% Deferred commercial revenue
---
RCEL Stock 12 Months Forecast
Average Price Target
$26.80
▲(176.29% Upside)
Technical Analysis
Best Analysts Covering RCEL
1 Year
1 Year Success Rate
3/13 ratings generated profit
1 Year Average Return
-15.28%
reiterated a buy rating 9 days ago
Copying Matthew O'Brien's trades and holding each position for 1 Year would result in 23.08% of your transactions generating a profit, with an average return of -15.28% per trade.
---